Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
Press releases published on May 2, 2025
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 2, 2025
On track for six major study readouts across four programs over the next 12 months Ready to initiate pivotal studies in two developmental and epileptic encephalopathy (DEE) programs in mid-year 2025: EMERALD for broad DEEs with relutrigine and EMBRAVE3 for …
Draganfly Announces Pricing of US$3.6 Million Underwritten Public Offering
GlobeNewswire
·
May 2, 2025
Saskatoon, SK., May 02, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the pricing of its previously announced underwritten public …
Yocbit Releases Latest Data: Global Users Exceed 8 Million, Daily Trading Volume Steadily Surpasses $1.2 Billion, Accelerating Global Compliance Strategy
GlobeNewswire
·
May 2, 2025
New York, May 02, 2025 (GLOBE NEWSWIRE) -- Leading global digital asset trading platform Yocbit has officially released its latest operational data, showcasing strong growth momentum in the global digital economy. As of April 2025, the number of registered …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
May 2, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 2 May 2025 at 15.15 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
May 2, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 2.5.2025 KLO 15.15 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Maris-Tech Expands European Reach with New Distribution Agreement in Poland
GlobeNewswire
·
May 2, 2025
Collaboration with Armit Addresses Growing Demand for Defense Video …
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
GlobeNewswire
·
May 2, 2025
MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss …
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
GlobeNewswire
·
May 2, 2025
LEIDEN, Netherlands …
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
GlobeNewswire
·
May 2, 2025
BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium …
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
GlobeNewswire
·
May 2, 2025
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …
CareCloud Announces Preferred Stock Dividend Payments
GlobeNewswire
·
May 2, 2025
SOMERSET, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
GlobeNewswire
·
May 2, 2025
ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (“ECOR,” “electroCore,” or the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today the completion of the merger (the “Merger”) with NeuroMetrix, …
ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
May 2, 2025
SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …
Vislink Reports Fourth Quarter and Full Year 2024 Financial and Operational Results
GlobeNewswire
·
May 2, 2025
Mt. Olive, NJ, May 02, 2025 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCQB: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and …
iBio Reports Fiscal Third Quarter 2025 Financial Results
GlobeNewswire
·
May 2, 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq:IBIO), today reported financial results for the third quarter ended March 31, 2025, and provided a corporate update on its progress. “During the third quarter we were able to broaden our access …
ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
GlobeNewswire
·
May 2, 2025
Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …
SCROOGE Casino Launches Revolutionary VIP Rakeback Program Amid Social Impact Expansion
GlobeNewswire
·
May 2, 2025
Alexandria, Indiana, May 02, 2025 (GLOBE NEWSWIRE) -- SCROOGE Casino, a pioneering force in purpose-driven social gaming, announced its comprehensive VIP Rakeback Program today, set to debut in May 2025. This initiative arrives as the company continues to …
Trumpcoin ($TRUMP) Surged 30% In April As The Buzz Around Cloud Mining Grew; Investors Seeking Daily Profits With ZA Miner
GlobeNewswire
·
May 2, 2025
Middlesex, UK, May 02, 2025 (GLOBE NEWSWIRE) -- Donald Trump is turning up the heat in the crypto space, taking his involvement beyond public statements and into direct digital action. His meme coin, $TRUMP, has recently sparked major attention, shooting …
Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 2, 2025
– Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for topline data readout in the second quarter 2025 – – Tourmaline expects to provide further details on the clinical …